Free Trial

APG Asset Management US Inc. Sells 3,791 Shares of HCA Healthcare, Inc. (NYSE:HCA)

HCA Healthcare logo with Medical background

APG Asset Management US Inc. decreased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 48.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,000 shares of the company's stock after selling 3,791 shares during the period. APG Asset Management US Inc.'s holdings in HCA Healthcare were worth $1,201,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in HCA. Whipplewood Advisors LLC acquired a new position in HCA Healthcare in the fourth quarter valued at about $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $36,000. Activest Wealth Management increased its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. lifted its holdings in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Finally, Eastern Bank acquired a new position in shares of HCA Healthcare during the fourth quarter valued at about $62,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on HCA shares. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. StockNews.com downgraded shares of HCA Healthcare from a "buy" rating to a "hold" rating in a report on Wednesday, April 9th. Truist Financial lowered their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Royal Bank of Canada cut their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $385.67.

Check Out Our Latest Analysis on HCA

HCA Healthcare Trading Up 0.4 %

Shares of HCA stock traded up $1.47 during trading hours on Monday, hitting $334.84. 320,239 shares of the company's stock traded hands, compared to its average volume of 1,386,977. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock's 50 day simple moving average is $327.53 and its 200 day simple moving average is $336.07. The stock has a market cap of $82.44 billion, a PE ratio of 15.24, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm earned $5.90 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's dividend payout ratio is currently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by insiders.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines